Clinical trials
Not yet recruiting Phase 1 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
460 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 54 |
| 2025 | 116 |
| 2026 | 260 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 460 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 10 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 10 |
| Zhejiang University | 10 |
| Shenzhen Geno-Immune Medical Institute | 9 |
| Akeso | 8 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 8 |
| Chinese PLA General Hospital | 8 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 7 |
| Ruijin Hospital | 7 |
| Qilu Pharmaceutical Co., Ltd. | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 20 |
| Recurrence | 20 |
| Multiple Myeloma | 13 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Colorectal Neoplasms | 12 |
| Leukemia, Myeloid, Acute | 12 |
| Obesity | 12 |
| Hematologic Neoplasms | 11 |
| Autoimmune Diseases | 10 |
| Burkitt Lymphoma | 9 |
Trials
Showing 1 to 25 of 460. Each trial links to its page on Pharma Observatory.
360 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.